Page last updated: 2024-09-05

sorafenib and pr-104a

sorafenib has been researched along with pr-104a in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (pr-104a)	Trials (pr-104a)	Recent Studies (post-2010) (pr-104a)
6,520	730	5,251	25	2	19

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbattista, MR; Gu, Y; Guise, CP; Jamieson, SM; Nickel, JE; Patterson, AV; Pullen, SM; Wilson, WR	1

Other Studies

1 other study(ies) available for sorafenib and pr-104a

Article	Year
Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma. Cancer biology & therapy, 2015, Volume: 16, Issue:4 Topics: Animals; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Female; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Niacinamide; Nitrogen Mustard Compounds; Phenylurea Compounds; Prodrugs; Sorafenib; Xenograft Model Antitumor Assays	2015

Article

Year

Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma.

Cancer biology & therapy, 2015, Volume: 16, Issue:4

Topics: Animals; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Female; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Niacinamide; Nitrogen Mustard Compounds; Phenylurea Compounds; Prodrugs; Sorafenib; Xenograft Model Antitumor Assays

2015